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Abstract A common characteristic of ageing is
disrupted homeostasis between growth and atrophy
of skeletal muscle resulting in loss of muscle mass and
function, which is associated with sarcopenia. Sar-
copenia is related to impaired balance, increased falls
and decline in quality of life of older people. Ageing-
related transcriptome and proteome changes in skele-
tal muscle have been characterised, however the
molecular mechanisms underlying sarcopenia are still
not fully understood. microRNAs are novel regulators
of gene expression known to modulate skeletal muscle
development and homeostasis. Expression of numer-
ous microRNAs is disrupted in skeletal muscle
with age however, the functional consequences of this
are not yet understood. Given that a single microRNA
can simultaneously affect multiple signalling path-
ways, microRNAs are potent modulators of
pathophysiological changes occurring during ageing.
Here we use microRNA and transcript expression
profiling together with microRNA functional assays to
show that disrupted microRNA:target interactions
play an important role in maintaining muscle home-
ostasis. We identified miR-181a as a regulator of the
sirtuin1 (Sirt1) gene expression in skeletal muscle and
show that the expression of miR-181a and its target
gene is disrupted in skeletal muscle from old mice.
Moreover, we show that miR-181a:Sirt1 interactions
regulate myotube size. Our results demonstrate that
disrupted microRNA:target interactions are likely
related to the pathophysiological changes occurring
in skeletal muscle during ageing.
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Introduction
Age-related loss of skeletal muscle mass and function,
associated with sarcopenia, results in frailty, decline in
strength and decrease in quality of life of older people.
The mechanisms of age-related defective muscle
homeostasis related to hypertrophy/atrophy are mul-
tifactorial and depend on a number of changes
including mitochondrial production of reactive oxy-
gen species (Jackson and McArdle 2011), changes in
the muscle niche (Carlson and Conboy 2007), or
alterations in circulating factors (Carlson et al. 2009).
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Moreover, skeletal muscles of adult and old animals
display substantially different gene (Welle et al. 2003;
Sifakis et al. 2013) and protein (McDonagh et al.
2014) expression profiles.
microRNAs (miRNAs) are small, non-coding
RNAs that regulate gene expression at the post-
transcriptional level. miRNAs are predicted to regu-
late two-thirds of the human genome, suggesting that
miRNAs modulate many physiologically relevant
processes (Friedman et al. 2009). Mature miRNAs
are generated from primary-miRNA (pri-miRNA)
precursors which are cleaved by the enzyme Drosha
forming the pre-miRNA transcript. The pre-miRNA is
transported into the cytoplasm, where the enzyme
Dicer generates a 19–24 base pair miRNA duplex
(Bartel 2004). The mature miRNA strand is incorpo-
rated into the RISC complex (RNA Induced Silencing
Complex). The non-incorporated strand is often
degraded however it may also be incorporated into
the RISC. miRNAs guide the RISC to partially
complementary sequences, usually contained within
the 30 UTR of target mRNA transcripts, resulting in
target mRNA degradation and/or inhibition of trans-
lation. Most mammalian miRNAs have only partially
complementary sequences to their target mRNAs
(Bartel 2004) resulting in challenging bioinformatic
prediction of the target genes.
microRNAs play significant roles in myogenic
processes during embryonic development (Goljanek-
Whysall et al. 2011, 2014) and in adults by regulating
satellite cell function, muscle hypertrophy and myofi-
bre type (McCarthy and Esser 2007; Crist et al. 2009;
Van Rooij et al. 2009b; Goljanek-Whysall et al. 2012;
Brown and Goljanek-Whysall 2015; Soriano-Arro-
quia et al. 2016). Moreover, the role of miRNAs in
muscle during ageing has been demonstrated using
satellite cell specific Dicer-deficient mice (Cheung
et al. 2012), characterised by mild muscle atrophy and
an impaired ability to regenerate muscle fibres
following muscle injury. The differential expression
of many muscle-enriched as well as non-muscle
specific miRNAs in skeletal muscle during ageing in
multiple species, including mice (Kim et al. 2014a),
rats (Hu et al. 2014a), rhesus monkeys (Mercken et al.
2013) and humans (Drummond et al. 2011a; Rivas
et al. 2014b; Zacharewicz et al. 2014) has been
demonstrated. Moreover, differential expression of
miRNAs in skeletal muscle of adult and old humans in
response to an acute bout of resistance exercise has
been shown (Rivas et al. 2014a; Zacharewicz et al.
2014). Soares et al. (2014) recently demonstrated that
different catabolic conditions in muscle are associated
with a unique and dynamic miRNA signature (Soares
et al. 2014).
In this study, we aimed to establish the potential
functional consequences of age-related dysregulation
of microRNA:target interactions in skeletal muscle
during ageing. We characterised the global changes in
microRNA and mRNA expression profiles in skeletal
muscle of adult and old mice using bioinformatics
tools and modelling. Moreover, we identified a group
of microRNAs, expression of which is affected by
ageing in mice and humans and validated the ageing-
associated changes in their expression in mouse
skeletal muscle. We demonstrated that miR-181a is
predicted to play a central role in ageing-related
disrupted muscle homeostasis and validated differen-
tial expression of microRNA-181a and its target genes
in skeletal muscle during ageing. Finally, we validated
Sirt1 as a miR-181a target and demonstrated that
manipulation of miR-181a expression regulates myo-
tube size in vitro. These data suggest that ageing-
associated changes in miR-181a and expression of its
target gene(s) may indeed be associated with the
ageing-related disrupted balance between muscle
hypertrophy and atrophy.
Materials and methods
Mice
The study was performed using male wild type C57Bl/
6 mice obtained from Charles River (Margate). All
mice were maintained under specific-pathogen free
conditions, fed ad libitum a standard chow and main-
tained under barrier on a 12-h light–dark cycle. For
tissue collection, mice were culled by cervical dislo-
cation. The tissues were immediately excised, frozen
and stored at-80 C. Experiments were performed in
accordance with UKHomeOffice guidelines under the
UK Animals (Scientific Procedures) Act 1986 and
received ethical approval from the University of
Liverpool Animal Welfare and Ethical Review Body
(AWERB). For microarray studies, n = 3 adult
(6 month) and n = 3 old (24 month) mice were used;
for qPCR validation, an independent cohort of
n = 6–9 adult and n = 4–6 old mice was used.
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microRNA and mRNA expression profiling
in skeletal muscle of adult and old mice
The tibialis anterior muscles (30–40 mg each) from
adult and old mice were dissected and RNA was
isolated using Trizol as described below. RNA
integrity was assessed using a Bioanalyser instrument
(Agilent Technologies) and samples with RIN[ 7
were used. An Affymetrix FlashTag Labelling kit and
GeneChip microRNA 3.0 arrays were used for global
miRNA expression profiling. GeneChip Mouse Gene
2.0 ST arrays (Affymetrix) were used for global
transcriptomic analysis. Data pre-processing, mod-
elling and differential expression analyses were car-
ried out using the Expression Console and
Transcriptome Analysis Control (Affymetrix) in the
R environment (http://cran.r-project.org) using pack-
ages from the Bioconductor project (http://www.
bioconductor.org). The oligo package (Carvalho and
Irizarry 2010) has been developed for use with Affy-
metrix Gene ST arrays and takes into account the lack
of incorporation of mismatch probes into the chip
architecture. Raw Data distributions were initially
visualised and assessed for spatial artefacts, array
clustering, technical variability between arrays and to
identify outliers prior to carrying out background
correction, normalisation and summarisation using
Robust Multichip Averaging (RMA). There were no
outlying samples identified in the dataset, therefore
n = 3 persists through to the differential expression
analysis and the full sample set is represented. Data
was then filtered for low variance using the genefilter
package. Modelling and statistical analysis of differ-
entially expressed genes was carried out in the limma
package (Smyth 2004; Smyth et al. 2005; Ritchie et al.
2006, 2015). Two-group comparisons were used to
determine statistically significant, differentially
expressed transcript clusters using an empirical Bayes
moderated t test. The Benjamini-Hochberg method
was used for false discovery rate correction of p-val-
ues. For changes in microRNA expression in human
skeletal muscle, publically available datasets were
used (GSE23527; (Drummond et al. 2011b; Rivas
et al. 2014a).
microRNA:target interaction predictions
Analysis of differentially expressed microRNAs and
mRNAs and predicted microRNA target genes was
completed using QIAGEN’s Ingenuity Pathway
Analysis (IPA) Product (Ingenuity Systems,
http://www.ingenuity.com), specifically the Core
Analysis function, the Path Designer feature and the
microRNA Target Filter. A list of experimentally
validated and predicted microRNA targets was pro-
duced based on Targetscan Human, TarBase, miR-
ecords, Ingenuity Expert Findings and Ingenuity
ExpertAssist Findings.
Cell culture and transfections
C2C12 cells were cultured in Dulbecco’s modified
medium (DMEM) supplemented with 10 % fetal
bovine serum (FBS), 1 % L-glutamine and 1 %
penicillin/streptomycin. To induce myogenic differ-
entiation, 90 % confluent cells were cultured in
DMEM supplemented with 2 % horse serum, 1 %
L-glutamine and 1 % penicillin/streptomycin (Gol-
janek-Whysall et al. 2012).
Myotubes were transfected with either 100 nM
miRNA-181, 100 nM antimiR-181 or 2.5 lg SIRT1
overexpression vector (Addgene, 1791) (Brunet et al.
2004) using Lipofectamine 2000TM.Mock-transfected
or antimiR-scrambled-transfected cells served as
controls. Transfection efficiency was 40–50 %,
depending on the molecule transfected as described
previously (Goljanek-Whysall et al. 2012). To assess
the changes in myotube diameter following the
transfections, MF20 (myosin heavy chain) immunos-
taining was performed at 4 days post- transfection.
Real-Time PCR and western blotting
RNA isolation and quantitative real time PCR were
performed using standard methods as described pre-
viously (Goljanek-Whysall et al. 2014). cDNA syn-
thesis (mRNA) was performed using 400–500 ng
RNA and SuperScript II according to the manufac-
turer’s protocol. cDNA synthesis (microRNA) was
performed using 100 ng RNA and miRscript RT kit II
according to the manufacturer’s protocol. microRNA
qPCR analysis was performed using miRScript Sybr-
Green Mastermix in a 20 ll reaction according to the
manufacturer’s protocol. mRNA qPCRwas performed
using sso-Advanced SybrGreenMastermix, using 1 ll
of 10lM each primer in 20 ll reaction. All amplicons
were designed to span an intron–exon junction (where
mRNAs consisted of more than one exon) and were
Biogerontology (2016) 17:641–654 643
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200–300 nt long. Expression relative to b-2
microglobulin and/or 18S (mRNA) or Rnu-6 and/or
Snord-61 (microRNA) was calculated using the delta
delta Ct method. The qPCR conditions were: 95 C
10 s, 55 C (miRNA) or 60 C (mRNA) 30 s, 72 C
30 s (40x). Protein lysis and Western blots were
performed as described (Goljanek-Whysall et al.
2014). The primers and reagents used are listed in
Tables S4 and S5, respectively.
In vitro miRNA target validation
Predicted target genes of miR-181 were initially
chosen based on the global profiling data. Next our
own and published data were used to narrow down the
list of potential candidate targets to the ones that may
be relevant to muscle ageing. The 30UTR region of
Sirt1with a wild type (WT) or mutated miR-181 target
site (mutant) were synthesised using GeneArt service
(Invitrogen) and cloned into a GFP TOPO vector
(Invitrogen). C2C12 myotubes cultured in 6-well
plates were transfected using Lipofectamine 2000TM
with WT or mutant constructs (1000 ng), with or
without miRNA mimic (50 nM). Protein was
extracted after 48 h and GFP expression analysed by
Western blotting.
Results
Ageing affects microRNA:target interactions
in skeletal muscle of mice
To model microRNA:target interactions in skeletal
muscle during ageing, an unbiased microRNA and
mRNA expression profiling was performed on the
tibilais anterior (TA) muscle of adult and old mice
using microarrays (Figure S1). The expression of 16
microRNAs was significantly downregulated and the
expression of 14 microRNAs was significantly upreg-
ulated in muscle during ageing (Table 1). Among the
differentially expressed microRNAs were miR-181a,
miR-208-5p or miR-499, miR-130a, miR-26a and
miR-30c with previously characterised functions in
skeletal muscle.
Given the potential of miRNAs to regulate a large
number of cellular transcripts, transcript expression
profiling was performed. The expression of only 12
transcripts was significantly downregulated and the
expression of 19 mRNAs was significantly upregu-
lated in the TA muscle of old mice compared with the
muscle of adult mice (p\ 0.05; Table 2). This low
number of differentially expressed genes in muscle
during ageing may be related to a limited number of
Table 1 microRNAs
differentially expressed in
the tibialis anterior muscle
of mice during ageing
microRNA expression was
assessed in the TA muscle
of adult and old mice; the
microRNA identity and fold
change are given.
MicroRNAs previously
noted to be differentially
expressed in human skeletal
muscle during ageing are
highlighted in red; adult:
6 months old; old:
24 months old; n = 3
microRNA
downregulated
during ageing
Fold Change
(Old vs Adult)
p value microRNA
upregulated during
ageing
Fold Change
(Old vs Adult)
p value
miR-122 -19.64 0.039 miR-26a 1.49 0.0004
miR-382 -6.17 0.038 mir-499 1.48 0.001
miR-148a -4.31 0.038 miR-5103 1.32 0.002
miR-344f-5p -3.41 0.038 miR-34b-3p 3.15 0.002
miR-132 -2.63 0.003 miR-669 g 1.31 0.003
miR-379 -2.39 0.028 mir-669o 1.76 0.004
miR-301a -2.26 0.044 miR-217* 1.12 0.005
miR-30c* -2.06 0.00002 mir-5123 1.63 0.005
miR-127 -2.05 0.004 miR-1186 2.05 0.008
mir-181a -1.52 0.001 miR-431* 2.51 0.009
miR-208a-5p -1.5 0.00 mir-669 m 2.15 0.016
mir-3074-1 -1.36 0.005 miR-467b* 3.1 0.016
miR-471-3p -1.32 0.002 miR-133a* 2.39 0.033
miR-3475 -1.29 0.004 miR-872* 2.23 0.049
miR-465c-3p -1.19 0.0006
mir-3063 -1.18 0.004
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biological replicates (n = 3). Among the genes dif-
ferentially expressed during ageing were genes asso-
ciated with metabolism and mitochondrial function:
Ucp3, Pdk4; methylation: Mettl21c; DNA damage
response:Gadd45 g; retinoic acid signalling: Rarres1;
as well as cellular senescence: Cdkn1 (p21).
To understand the biological relevance of the
changes in microRNA expression during ageing,
microRNA: predicted target interactions were mod-
elled using miRSystem (http://mirsystem.cgm.ntu.
edu.tw/index.php). The top pathway predicted to be
regulated by microRNAs downregulated in muscle
Table 2 Transcripts differentially expressed in the tibialis anterior muscle of mice during ageing
Gene Symbol (transcripts
downregulated)
Fold change
(Old vs Adult)
p value Description
Krt10 -7.61 0.030813 keratin 10
Arrdc2 -4.87 0.034934 arrestin domain containing 2
Dsc1 -3.55 0.033618 desmocollin 1
Dsg1a -3.51 0.042671 desmoglein 1 alpha
Krt77 -3.31 0.046219 keratin 77
Hrnr -3.07 0.014021 hornerin
Gm24202 -3.05 0.04403 predicted gene, 24202
Pof1b -2.93 0.039252 premature ovarian failure 1B
Mettl21c -2.88 0.008667 methyltransferase like 21C
Ucp3 -2.75 0.003941 uncoupling protein 3 (mitochondrial, proton carrier)
Neto2 -2.61 0.046314 neuropilin (NRP) and tolloid (TLL)-like 2
Gm24128 -2.4 0.032397 predicted gene, 24128
Lce1 m -2.39 0.014247 late cornified envelope 1 M
Slc25a30 -2.37 0.006328 solute carrier family 25, member 30
Gadd45g -2.34 0.001227 growth arrest and DNA-damage-inducible 45 gamma
Nrep -2.1 0.003032 neuronal regeneration related protein
Rarres1 -2.04 0.037197 retinoic acid receptor responder (tazarotene induced) 1
Zfp640 -2.02 0.03305 zinc finger protein 845-like; zinc finger protein 640
Pdk4 -2.01 0.002642 pyruvate dehydrogenase kinase, isoenzyme 4
Gene Symbol
(transcripts upregulated)
Fold Change
(Old vs Adult)
p-value Description
Krt18 3.76 0.002333 keratin 18
Cpne2 3.02 0.002247 copine II
Igkv4-57-1 2.75 0.023636 immunoglobulin kappa variable 4-57-1
Nabp1 2.49 0.007488 nucleic acid binding protein 1
Cilp 2.48 0.002913 cartilage intermediate layer protein, nucleotide
pyrophosphohydrolase
Tnfrsf23 2.41 0.005439 tumor necrosis factor receptor superfamily, member 23
Rrad 2.25 0.009309 Ras-related associated with diabetes
Cdkn1a 2.21 0.018982 cyclin-dependent kinase inhibitor 1A (P21)
Gm6821 2.19 0.009309 predicted gene 6821
Ankrd1 2.17 0.008222 ankyrin repeat domain 1 (cardiac muscle)
Gm26179 2.11 0.035369 predicted gene, 26179
Trim30a 2.1 0.006883 tripartite motif-containing 30A
Target name and description, fold change in expression and p value are given; adult 6 months old; old 24 months old; n = 3
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during ageing was the insulin signalling pathway with
137 microRNA putative targets being associated with
this pathway (Table 3). Targets of microRNAs
upregulated during ageing were associated with pro-
tein processing in endoplasmic reticulum, splicing and
ubiquitin-mediated proteolysis (Table 3).
Analysis of microRNA:target interactions using
Ingenuity pathways indicated that ubiquitin-mediated
proteolysis, mitochondrial metabolism, insulin sig-
nalling and splicing were regulated by microRNAs
downregulated in muscle during ageing, whereas cell
senescence, TGFb (transforming growth factor beta),
NF-kB (nuclear factor jB) and MAPK (mitogen-
activated protein kinase) signalling were mainly
regulated by microRNAs upregulated in muscle
during ageing (Fig. 1). Further pathway analysis using
Ingenuity was performed to determine which miRNAs
and their target genes form networks of connections.
We observed that there were several genes and
microRNAs forming nodes in the interaction network
that comprised differentially expressed mRNAs and
microRNAs and their predicted target genes (Fig. S2).
Genes associated with ubiquitin-mediated proteolysis,
cell cycle, NF-kB and insulin signalling, as well as
miRs miR-132, miR-122, miR-499, miR-128 and
miR-22 formed central nodes in the network of
miRNA:target interactions disrupted during ageing
(Fig. S2).
Overall, these data indicate that several miRNA:-
target interactions are deregulated in skeletal muscle
during ageing. These changes are likely to contribute
to ageing-related pathophysiological processes, such
as loss of muscle mass and function through regulation
of ubiquitin-mediated proteolysis, ER stress and NF-
jb signalling, senescence associated with disrupted
cell cycle or myofibre hypertrophy associated with
insulin signalling.
A set of microRNAs is deregulated during ageing
in muscle of human and mice
Publically available datasets were examined for dif-
ferential expression of microRNAs in human skeletal
muscle during ageing (Drummond et al. 2011b;
Rivas et al. 2014a) in order to establish whether a
specific set of miRNAs was affected by ageing in
both mouse and human skeletal muscle. Only 7
microRNAs were consistently deregulated during
ageing in human and mouse skeletal muscle (Table 1;
miRs highlighted in red). Ingenuity pathways analysis
indicated that differential expression of these 7
microRNAs and consequently their target genes
may result in defective insulin, MAPK and TGFb
Table 3 Functional
annotation of predicted
targets of microRNAs
differentially expressed in
skeletal muscle of mice
during ageing; term—
functional annotation term
associated with miRNA
predicted target genes
TERM (Predicted targets of downregulated mirnas) Total genes p value
Insulin signaling pathway 137 4.05E-02
Carbohydrate digestion and absorption 39 4.06E-02
Starch and sucrose metabolism 44 4.45E-02
Type ii diabetes mellitus 49 4.95E-02
Amino sugar and nucleotide sugar metabolism 47 6.56E-02
Glycolysis gluconeogenesis 60 9.10E-02
Fructose and mannose metabolism 36 9.26E-02
Galactose metabolism 27 2.62E-01
TERM (Predicted targets of upregulated mirnas)
Endoplasmic reticulum 167 3.01E-01
Rna transport 150 2.82E-01
Ubiquitin mediated proteolysis 138 1.59E-01
Spliceosome 126 3.25E-01
Erbb signaling pathway 87 6.63E-02
cFig. 1 Disrupted microRNA:target interaction networks in
skeletal muscle of mice during ageing. The network of
interactions was constructed using IPA software. The inputs
were microRNAs and their predicted targets and mRNAs
differentially expressed in muscle during ageing. In red
miRs/genes that were downregulated with age are shown; in
green miRs/genes that were upregulated with age are shown. a.
Networks of interactions associated with miRs downregulated in
muscle during ageing. b. Networks of interactions associated
with miRs upregulated in muscle during ageing
646 Biogerontology (2016) 17:641–654
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signalling, with microRNA-181a being central to
controlling these interactions. Interestingly, miR-181a
is predicted to target several hundred genes (Figs. 2,
S3), including genes associated with p38, NF-kB and
TGFb signalling, as well as genes previously reported
to play an important role in skeletal muscle, such as
Sirt1, Pten and Nfatc1 (Figs. 2, S3).
qPCR was used to validate the differential expres-
sion of the 7 microRNAs in the skeletal muscle of mice
during ageing. The differential expression ofmiR-181a,
miR-133a, miR-26a, miR-499, miR-34b and miR-30c
was validated in muscle during ageing (Fig. 3a, b).
Since miR-181a, but not miR-181d, expression was
significantly affected by ageing and it was predicted to
have a central role in the microRNA:mRNA interac-
tions affected by ageing, we analysed the expression of
several miR-181a predicted target genes associated
with muscle function by qPCR and western blot
(Fig. 3c, d). We were unable to detect significant
changes in the expression of Pten and Meox2 at the
mRNA and/or protein level (Fig. 3c, d). Among the
analysed miR-181a predicted target genes, SIRT1
protein levels were significantly affected by ageing
(Fig. 3d, e). miR-181a and SIRT1 protein expression
were inversely correlated in muscle during ageing
suggesting that Sirt1 may be one of the key miR-181a
targets in skeletal muscle during ageing.
miR-181a directly regulates the expression of Sirt1
The 30UTR of Sirt1 has one putative miR-181 binding
site conserved between human and mouse (Fig. 4a).
To establish whether miR-181 directly interacts with
the Sirt1 30UTR, we generated a reporter construct
containing a fragment of the Sirt1 30UTR downstream
of a GFP reporter (‘‘wild type’’). ‘‘Mutant’’ reporter
contained a mutated miR-181 binding site. The GFP
reporter containing wild type Sirt1 30UTR was
efficiently regulated by miR-181 but not by miR-24;
a microRNA not predicted to target Sirt1 (negative
control) (Fig. 4b, c). Mutation of the putative target
site in the 30UTR rendered the reporter construct
insensitive to miR-181, indicating that interaction with
the target site is required for the response (Fig. 4b, c).
To validate Sirt1 as a physiologically relevant miR-
181 target gene in muscle, the expression of Sirt1
transcript and protein was examined in C2C12
myotubes following miR-181 overexpression or inhi-
bition using miRNA mimic or antimiR (AM181),
respectively (Fig. 4c, d). The efficiency of the trans-
fections was validated (Fig. S4). The expression of
SIRT1 protein, but not mRNA in C2C12 myotubes was
downregulated following overexpression of miR-181
and upregulated following inhibition of miR-181
function (Fig. 4d–f). These data show that miR-181a
directly regulated SIRT1 expression at the protein level.
Changes in miR-181a:Sirt1 affect myotube size
To establish whether age-related changes in miR-181a
expression may have functional consequences on
muscle homeostasis, C2C12 myotubes were used as
an in vitro model to studymyotube hypertrophy and/or
atrophy. C2C12 myotubes were transfected with
Fig. 2 Disrupted
microRNA:target
interaction network in
skeletal muscle of humans
and mice during ageing. The
network of interactions was
constructed using IPA
software. The input was
microRNAs and their
experimentally validated
targets
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miR-181 mimic or inhibitor (AM) or SIRT1 overex-
pression construct. At 4 days following transfection
myotubes were stained for myosin heavy chain
(MF20) and myotube diameter measured. miR-181a
overexpression led to a significant decrease in
myotube diameter, whereas miR-181a inhibition led
to an increase in myotube diameter as compared to
mock- and scrambled-transfected controls (Fig. 5).
SIRT1 overexpression resulted in an increased
myotube diameter as compared to mock- and scram-
bled- transfected controls (Fig. 5). Co-transfection of
SIRT1 overexpression construct together with miR-
181 mimic rescued the miR-181-induced phenotype,
indicating the importance of Sirt1 as miR-181 target
gene in controlling myotube size (Fig. 5).
The effect of changes in miR-181 and SIRT1
expression on the expression of p21, a cell cycle
regulator associated with senescence and upregulated
in muscle of older mice, was examined (Table 2;
Fig. S5). We did not detect significant changes in p21
mRNA expression following manipulation of miR-
181a levels, however p21 expression was downregu-
lated following SIRT1 upregulation in C2C12 myo-
tubes indicating that SIRT1 may play additional, miR-
181-independent function in muscle, such as regulat-
ing cell senescence (Fig. S5).
Fig. 3 Validation of the differential expression of miRNAs and
target mRNAs in muscle during ageing. a qPCR showing
expression (relative to Rnu-6) of miRs differentially expressed
in skeletal muscle of mice and/or humans. b qPCR showing
relative expression of miR-181a andmiR-181d relative to Rnu-6
in TA muscle of mice during ageing. c qPCR showing relative
(to b-2-microglobulin) expression of miR-181a predicted target
genes in muscle of mice during ageing. d Western blot and
quantification showing differential protein expression of miR-
181a predicted targets in TA muscle of mice during ageing.
Representative Western blots are shown. Error bars show SEM;
n = 4–7; *p\ 0.05
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These data suggest that changes in miR-181a and
expression of its target gene Sirt1 in skeletal muscle
during ageing may indeed have functional conse-
quences on muscle homeostasis, specifically myofibre
hypertrophy and/or atrophy.
Discussion
The molecular mechanisms involved in sarcopenia
development are not fully understood, however it is
clear that transcriptomic, proteomic and epigenetic
changes are involved. miRNAs can simultaneously
modulate many signalling pathways and are therefore
likely to be high-throughput regulators of pathophys-
iological changes associated with sarcopenia.
We have identified and validated miRNAs and
mRNAs differentially expressed in skeletal muscle
during ageing. In mouse muscle (TA), 30 miRNAs
were differentially expressed during ageing (Table 1).
Of these, 7 miRNAs were differentially expressed
during ageing in the skeletal muscle of mice and
humans based on data presented here and deposited in
publically available databases (Drummond et al.
2011b; Rivas et al. 2014a). 5 microRNAs with a role
in muscle biology: miR-26a (Dey et al. 2012), miR-
499 (van Rooij et al. 2009a), miR34b (Roberts et al.
2012), miR-30c (Ketley et al. 2013) and miR-181a
(Naguibneva et al. 2006) were validated as differen-
tially expressed during ageing in the skeletal muscle of
mice (Fig. 3a). The differential expression of the
miRNAs during ageing was validated in whole muscle
rather than myofibres and therefore it is possible that
age-related changes in muscle quality, such as
adipocyte or immune cell infiltration, may be associ-
ated with changes in microRNA expression. Never-
theless, these data suggest that deregulation of
microRNA expression during ageing may have func-
tional consequences related to disrupted muscle
homeostasis.
Previous studies have investigated changes in the
expression of miRNAs in muscle during ageing
(Drummond et al. 2011b; Hu et al. 2014b; Kim et al.
2014b), however it is noteworthy, that the overlap in
Fig. 4 miR-181a represses Sirt1 expression in myotubes.
a Alignment of putative miR-181a target site in the 30UTR of
Sirt1 gene; human and mouse sequence are indicated; conserved
miR-181a putative target site is indicated in red; complementary
nucleotides are shown in orange, miR-181a seed sequence is
shown in blue. b GFP-Sirt1 30UTR sensor constructs containing
conserved mouse wild type or mutated miR-181a target site
were transfected into mouse myoblasts. Co-transfection with
miR-181a mimic but not miR-24 mimic, led to downregulation
of GFP protein expression compared to mock-transfected
control (Ctrl), as shown by representative western blot. Point
mutations in the microRNA target site (mutant) rendered the
sensor construct unresponsive. c Quantification of western blots
is shown. d, e Endogenous SIRT1 protein but not mRNA
expression is regulated by miR-181 in C2C12 myotubes, as
shown by representative Western blot or qPCR, respectively.
f Quantification of Western blots is shown. Error bars show
SEM; *p\ 0.05 (compared with control or scrambled control as
indicated); n = 3
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deregulated miRNA expression in muscle of old
animals between different studies is limited. This
may be due to the use of different transcriptomic
platforms or differential ageing processes in anatom-
ically distinct muscle types. Standardising research
methods used to globally profile changes in miRNA
expression in different types of muscle and organisms
would be an important step forward towards a better
understanding of the role of microRNAs in the decline
of muscle mass and function during ageing.
Using miRSystem and Ingenuity pathways, we
modelled microRNA:target interactions affected by
ageing. Our data indicates that deregulated miRNA:-
target interactions may be responsible for ageing-
related pathophysiological processes in skeletal mus-
cle through regulation of ubiquitin-mediated proteol-
ysis, ER stress and NFjB signalling, senescence and
splicing factor expression, previously reported to be
affected by ageing (Carvalho et al. 1996; Brack et al.
2007; Deldicque 2013; Holly et al. 2013; Drummond
et al. 2014). Interestingly, Ubc, Ucp3 and IGF
signalling pathways were also predicted to be a part
of the disrupted microRNA:target interactions during
ageing (Fig. S2). As the anabolic action of insulin is
reduced in muscle during ageing, and as muscle
absorbs large amounts of circulating glucose, changes
in IGF signalling in muscle during ageing could affect
the levels of circulating glucose and therefore glucose
present in other tissues, therefore affecting metabo-
lism (Rasmussen et al. 2006).
Further analysis of the interactome of miRNAs
differentially expressed during ageing in mouse and
human muscle revealed that insulin, MAPK and TGFb
signalling, as well as ER stress, are likely to be
regulated by these microRNAs; with miR-181a poten-
tially playing a key role in age-associated changes in
gene expression and signalling pathways in muscle.
The analysis of miR-181a predicted targets supports
this hypothesis, as miR-181a predicted target genes
include genes/pathways with known role(s) in main-
taining muscle homeostasis, for example Sirt1, Pten,
and p38, Tgfb, Tnfa, NF-kB and insulin signalling
pathways (Fig. S3). miR-181a has been previously
shown to regulate muscle regeneration (Naguibneva
Fig. 5 miR-181 negatively regulates myotube size by targeting
Sirt1. Expression of miR-181 and its target gene, Sirt1, was
manipulated in C2C12 myotubes; following transfections
myotubes were stained for myosin heavy chain: MF20 - green;
DAPI-blue. a MF20 immunostaining showing myotube size
regulation by miR-181a and Sirt1. b Quantification of myotube
diameter is shown (lm). Error bars show SEM, *p\ 0.05
(compared to control), n = 4
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et al. 2006) and downregulation of its expression may
be also related to deterioration of satellite cell function
and impaired regeneration of muscle during ageing.
miRNAs provide a potent and highly responsive
mechanism enabling cells to react to changes in their
environment by controlling cellular protein content
through regulating the expression of multiple target
genes. It is therefore important to characterise miRNA
target gene(s) when establishing miRNA function. We
have validated differential expression of miR-181a and
mRNA and analysed protein expression of miR-181a
predicted targets genes: Sirt1, Pten, Meox2, in the
mouse TA muscle during ageing (Fig. 3). Sirt1 is a
member of the sirtuin family, a NAD? -dependent
protein deacetylase known for its protective anti-ageing
effects and also shown to promote muscle hypertrophy
(Lee and Goldberg 2013; Sin et al. 2015). Meox2
controls muscle size and myofibre metabolism (Otto
et al. 2010), whilst Pten inhibition improves muscle
regeneration (Hu et al. 2010). Among miR-181a
predicted targets, SIRT1 protein levels were signifi-
cantly changed in muscle during ageing (Fig. 3). We
have validated Sirt1 as a physiologically relevant direct
miR-181a target in C2C12 myotubes (Fig. 4) and
showed that miR-181 regulates myotube size through
Sirt1, and potentially other target genes (Fig. 5). Since
the expression of miR-181a is downregulated and Sirt1
expression is upregulated in muscle during ageing, and
miR-181 negatively regulates myotube size, we suggest
that age-related changes in miR-181a and its target
gene(s) expression may act as a failing compensatory
mechanism intended to preventing loss of muscle mass
and potentially function. Previous data has shown that
such compensatory mechanisms exist. For example,
elevated levels of miR-206 in muscle of the amy-
otrophic lateral sclerosis (ALS)mousemodel have been
shown to compensate for the decreased neuromuscular
interactions (Williams et al. 2009). Future experiments
using in vivo model organism(s) will determine
whether age-related changes in miR-181a expression
may indeed act as a compensatory mechanism to
maintain muscle mass and potentially function during
ageing. It is noteworthy that Hu et al. (2014a, b) have
shown that deregulation of miR-29 expression in
muscle during ageing is associated with increased
muscle senescence and therefore it is likely that
changes in microRNA expression during ageing might
act as compensatory or causative events, depending on
the specific microRNA.
miRNAs present a potential to regulate a variety of
pathophysiological conditions, such as sarcopenia.
The ability to manipulate miRNA expression may
offer therapeutic potential for ameliorating sarcopenia
by modulating the rate of loss of muscle mass and
function with age. However, it is necessary to establish
the nature of changes in miRNA expression during
ageing, as well as the factors triggering these changes.
Furthermore, functional studies are needed to establish
whether miRNAs initiate ageing-related changes in
muscle homeostasis or fine-tune an already initiated
process, and whether some microRNAs act in a
compensatory manner to maintainmuscle homeostasis
in older individuals.
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